Viseon has announced the first clinical use of its “groundbreaking” Hubble AV system, marking what the company describes as a “major milestone” as it looks to expand into the neurosurgery market. Neurological surgery professor Gabriel Zada (University of Southern California [USC] Brain Tumor Center, Los Angeles, USA) performed the first Hubble AV case, treating a patient who underwent a right frontal craniotomy for a tumour resection.
“Neurosurgeons need minimally invasive solutions that improve visualisation, efficiency and extent of resection for complex cranial pathology,” Zada stated. “Hubble AV seamlessly combines 4K visualisation with lighting and graded suction into a single disposable device for rapid plug-and-play use for intracranial haematomas and tumours. Hubble AV provided dynamic visualisation and illumination in a deep cavity, and we achieved a complete evacuation of the haemorrhage and tumour.”
Hubble AV is a first-of-its-kind device that integrates aspiration, illumination and advanced 4K digital visualisation (4K-ADV) into a single, sterile, disposable instrument—”redefining” anatomical inspection and surgical efficiency, according to Viseon. Designed to seamlessly integrate with existing operating room (OR) equipment, the system provides “unprecedented surgical access” and enhanced visualisation for both open and minimally invasive procedures, the company further claims.
With low-profile 8Fr and 12Fr options, Hubble AV is intended to significantly reduce tissue manipulation compared to traditional cannula-based camera technologies, promoting better patient outcomes, and its cutting-edge imaging system tracks the distal tip of the device with the goal of eliminating the need for scope-based image repositioning.
“Hubble AV represents a paradigm shift in neurosurgical visualisation,” said Pete Davis, president and chief operating officer (COO) of Viseon. “By bringing our expertise from minimally invasive spine surgery into cranial surgery, we’re delivering a next-generation therapeutic solution that promotes improved clinical outcomes, OR engagement, and medical education, while reducing reliance on costly, capital-intensive microscopes, endoscopes and exoscopes. Hubble AV is the first device of several in development as Viseon begins its neuro-cranial product journey.”
In addition to Hubble AV, Viseon has a series of neurosurgery devices in development that the company believes will expand the use of its technology to treat a variety of patient conditions. A recent press release from Viseon notes that this broad product platform, combining 4K imaging with routinely used instruments, will create valuable therapeutic tools and smarter instruments, leading to superior clinical results and OR efficiencies compared to techniques and devices currently used by neurosurgeons.
